Dr. Gore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 Ne Pacific St
Seattle, WA 98195Phone+1 206-598-4294
Summary
- Dr. John Gore is a urologist and urologic oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including UW Medicine/University of Washington Medical Center, UW Medicine/Harborview Medical Center, and the Fred Hutchinson Cancer Center. He received his medical degree from Baylor College of Medicine and has been in practice 16 years. He is experienced in bladder cancer, kidney cancer, adrenal tumors, and robotic surgery.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 2001 - 2007
- Baylor College of MedicineClass of 2001
Certifications & Licensure
- MT State Medical License 2022 - 2026
- WA State Medical License 2009 - 2026
- AK State Medical License 2022 - 2025
- ID State Medical License 2022 - 2025
- CA State Medical License 2003 - 2012
- American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Characterizing Psychological Resources and Resilience in Patients With Bladder Cancer: Associations With Frailty and Quality of Life.Erin Petersen, Sarah Holt, Anne Browning, Dana Cavanaugh, Samia Jannat
The Journal of Urology. 2025-01-01 - Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study.Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, Sarah K Holt, Rishi R Sekar
Clinical Genitourinary Cancer. 2024-12-01 - Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.Sarah P Psutka, Susan Veleber, Jonathan Siman, Sarah K Holt, Samia Jannat
European Urology Oncology. 2024-12-01
Authored Content
- Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes SurveyMarch 2019
Press Mentions
- Black Men Face Grim Prostate Cancer Realities with SurgeryMarch 14th, 2023
- Bladder Cancer Advances Abound, but for Which Patients?October 6th, 2022
- Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101 in the OLYMPUS Trial - John GoreJuly 14th, 2022
- Join now to see all
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Urologic Imaging, American College of Radiology 2015 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: